Novavax Inc (NVAX) — Capital Reinvestment Ratio
Novavax Inc (NVAX) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow ($107.80 Million) in capital expenditures ($2.02 Million). See Novavax Inc (NVAX) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Novavax Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Novavax Inc's Capital Reinvestment Ratio across 1 annual periods. Check NVAX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Novavax Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Novavax Inc from 2021 to 2021. For live market cap and broader valuation context, see market cap of Novavax Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.18x | $322.95 Million | $57.49 Million | — |